Target intelligence / Profile preview

Anaerobic protozoal DNA (null)

Target
null
Molecular classification
Other (cellular nucleic acid); not a receptor, enzyme, transporter, or protein
01

Overview

Anaerobic protozoal DNA refers to the genetic material present in parasitic protozoa that thrive under oxygen-poor (anaerobic) conditions. These protozoa, including *Trichomonas vaginalis*, *Giardia lamblia*, and *Entamoeba histolytica*, possess specialized organelles (hydrogenosomes or mitosomes) enabling anaerobic metabolism and unique biochemical pathways for energy production[2][6]. Nitroimidazole class drugs selectively target anaerobic protozoal DNA, undergoing reduction by protozoal redox enzymes and producing toxic intermediates that result in DNA fragmentation, cell damage, and the death of the parasite. This class of drugs is widely used in the treatment of protozoal and certain anaerobic bacterial infections. Molecular variation, resistant strains, and drug safety must be considered when targeting these organisms[1][6].

Other names
Protozoal DNAAnaerobic protozoan DNAParasitic protozoan DNADNA of anaerobic protozoa
02

Mechanism of action

Nitroimidazole compounds are **activated inside anaerobic protozoa by reduction via ferredoxin and oxidoreductase enzymes in specialized organelles (hydrogenosomes, mitosomes)**[1][2][6]. The reduced drug forms **nitro radicals that chemically attack and fragment protozoal DNA**, preventing DNA synthesis and leading to cell death[1][6].

03

Biological functions

Genetic information storageRegulation of gene expressionTransmission of heritable traitsCell proliferationCellular metabolism
04

Disease associations

Infection (e.g., trichomoniasis, giardiasis, amoebiasis)
05

Safety considerations

Mutagenicity of nitroimidazole drugsCarcinogenicity risk (animal data)Effects on host (microbiome disruption)Resistance development in protozoa via altered DNA repair or drug activation pathways
06

Interacting drugs

Metronidazole

4 more in the full profile.

07

Biomarkers

Detection of protozoal nucleic acid (PCR or DNA-based diagnostic for *Trichomonas vaginalis*, *Giardia lamblia*, *Entamoeba histolytica*)Resistance genes (mutations in ferredoxin or oxidoreductase pathways)

Beyond the preview

Go deeper on Anaerobic protozoal DNA (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anaerobic protozoal DNA (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call